Investigational Site Number : 3920002

Okayama, Okayama-ken 701-1192

0 studies enrolling now · 2 studies all time

What they study most

Multiple Myeloma, Plasma Cell Myeloma Recurrent

Studies at this site

• SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM — Running, not enrolling
• Multi-center, Open-label, Phase 1b Study in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) — Completed